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A B S T R A C T
The objective of this research was to determine the dose–response effects of a palatable, viscous and gel
forming ﬁbre, PolyGlycopleX® (PGX®), [(α-D-glucurono-α–manno-β-D-manno-β-D-gluco), (α-Lgulurono-
β-D mannurono), (β-D-gluco-β-D-mannan)] on satiety, and to gain insight into the underlying mecha-
nisms that lead to appetite inhibition. Healthy subjects (n = 10), aged between 20.3 and 29.2 years, consumed
PGX®, in granular form at 2.5, 5.0 and 7.5 g, and a 5g inulin control, with a standard breakfast. The PGX®
doses of 2.5 and 7.5 g mixed with water at the start of breakfast increased satiety (iAUC of 140.0 and 157.7,
P = 0.025 and 0.001, respectively) compared to the control. The most effective dose (7.5g) was palatable
and corresponded to a 34% increase in fullness, measured using a visual analogue scale and incremental
area under the curve, and resulted in a delayed postprandial glycaemic response when compared with
the control.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Satiety is deﬁned as the sensation of fullness as a consequence
of eating that inhibits the resumption of eating (Gerstein,Woodward-
Lopez, Evans, Kelsey, & Drewnowski, 2004). Dietary and function-
al ﬁbre include naturally occurring edible and synthetic carbohydrate
polymers, non-starch polysaccharides including hydrocolloids (i.e.
gums, mucilage, β-glucan), resistant oligosaccharides, and resis-
tant starch, and have a physiological effect that is of beneﬁt to health
(Codex Alimentarius Commission, 2011; Phillips, 2011; Slavin, 2003).
The consumption of food with a high ﬁbre content has been linked
to enhanced satiety and may result in reduced energy intake, and
therefore plays a key role in weight regulation and the reduced risk
of disease (Burton-Freeman, 2000; Hull, Re, Tiihonen, Viscione, &
Wickham, 2012;Marciani et al., 2001; Paxman, Richardson, Dettmar,
& Corfe, 2008; Pelkman, Navia, Miller, & Pohle, 2007; Pereira &
Ludwig, 2001; Slavin & Green, 2007; Slavin, 2005).
The physical form of ﬁbre and viscosity has been shown to provide
higher satiety than nutrients, such as protein, alone (Hogenkamp,
Mars, Staﬂeu, & de Graaf, 2012; Marciani et al., 2001; Solah et al.,
2010). Food containing viscous ﬁbre has a beneﬁcial satiety effect
beyond that of non-viscous ﬁbre, and low-glycaemic foods are more
satiating compared to high-glycaemic foods (Holt & Brand-Miller,
1994; Holt, Brand-Miller, & Stitt, 2001). Vuksan et al. (2009) found
that high viscosity PolyGlycopleX® (PGX®), [(α-D-glucurono-α–
manno-β-D-manno-β-D-gluco), (α-Lgulurono-β-Dmannurono), (β-
D-gluco-β-D-mannan)] reduced hunger and ad libitum food
consumption when compared to low-viscosity cellulose and
medium-viscosity glucomannan, and when given as meal replace-
ment drinks. Different viscous ﬁbre types vary in the degree of vis-
cosity, and this increased viscosity, as well as subsequent gel
formation of some ﬁbres, may also result in nutrients being bound
for longer periods of time (Brand-Miller et al., 2010, 2012; Kristensen
& Jensen, 2011;Mars, Staﬂeu, & de Graaf, 2012;Mattes, 2007; Reimer
et al., 2010). Binding of nutrients may slow the release of glucose
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into the blood, affecting appetite-regulating peptides such as peptide
YY (PYY) and glucagon-like peptide-1 (GLP-1) (Grover et al., 2011).
Researchers have reported a dose response of different ﬁbre types
on satiety. In a 3-week, double blind, placebo controlled, cross-
over trial on 45 women, Kacinik et al. (2011) showed that adding
PGX® to meals during consumption of a low-calorie diet reduced
subjective ratings of prospective consumption and increased feel-
ings of satiety, when compared to the addition of a low viscosity
placebo. Similarly, an inverse dose–response effect of sodium algi-
nate, an algal gelling polysaccharide containing guluronic acid and
mannuronic acid units, on ad libitum food intake was found by
Wanders et al. (2013). Higher doses of a non-viscous dextrin,
NUTRIOSE®, increased satiety (Guérin-Deremaux et al., 2011). In con-
trast Van Nieuwenhoven, Kovacs, Brummer, Westerterp-Plantenga,
and Brouns (2001) found no effect of different doses of guar gum
on gastric emptying.
There are numerous and complex interactions in digestion, es-
pecially in a mixed meal, that complicate the issue of satiety
(Blackwood, Salter, Dettmar, & Chaplin, 2000; De Graaf, Blom, Smeets,
Staﬂeu, & Hendriks, 2004;Wanders et al., 2011). The satiety mecha-
nisms involving the consumption of dietary or functional ﬁbre may
involve a speciﬁc blood glucose level effect on satiety and other
stimuli effects such as that of peptides including cholecystokinin
(CCK), that are involved in the control of appetite (Bornet, Jardy-
Gennetier, Jacquet, & Stowell, 2007). Viscous dietary ﬁbre can slow
down gastric emptying and concurrently increase stomach disten-
sion (Hoad et al., 2009). Fullness may cause or inﬂuence the chain
of events that lead to satiation (De Graaf et al., 2004; Ritter, 2004),
and the physical and physicochemical properties of foods result in
various signals, which can contribute to satiation (Benelam, 2009;
Cummings & Overduin, 2007; Ritter, 2004). Viscosity inﬂuences gas-
trointestinal hormonal responses (Juvonen et al., 2009; Odunsi et al.,
2010), and gastrointestinal hormone release inﬂuences satiety
(Delzenne & Cani, 2005). The addition of dietary or functional ﬁbre
to food can decrease total energy intake and increase viscosity and
water holding capacity of digesta and cause the formation of gels
in the stomach (Blackwood et al., 2000; Hoad et al., 2004; Livesey,
1992; Poppitt & Prentice, 1996). The ﬁbre and water relationship is
an important aspect that must be considered in satiety studies.
Palatability, liking or pleasantness is increasingly measured in
dietary intervention studies to ensure that any beneﬁt offered in con-
suming the diet ismatched by dietary acceptance (Hall, Baxter, Fryirs,
& Johnson, 2010; Ibrügger, Kristensen, Mikkelsen, & Astrup, 2012).
A product that is palatable, satiating and delays postprandial gly-
caemia is important in regulating food intake, and has important
public health signiﬁcance in the control of obesity.
PolyGlycopleX, PGX®, is a commercial novel functional ﬁbre
complex (α-D-glucurono-α–manno-β-D-manno-β-D-gluco),
(α-Lgulurono-β-D mannurono), (β-D-gluco-β-D-mannan)
(Inovobiologic Inc., Calgary, Canada) and is manufactured by a pro-
prietary process (EnviroSimplex®) using three dietary ﬁbres to form
a highly viscous polysaccharide with high water holding and gel
forming properties.
The aims were to measure feelings of fullness and hunger, over
two hours, on a visual analogue scale of three doses of PGX® and a
control, and to determine if a relationship with plasma glucose over
the same two-hour time frame exists.
Methods
Study design
A single-blind, randomised controlled, crossover trial was con-
ducted on 10 healthy subjects, aged between 20.3 and 29.2 years,
selected from a pool of 16 pre-screened subjects. Subjects were re-
cruited through the Sydney University Glycaemic Index Research
Service volunteer roster. Criteria for inclusion were bodymass index
<25 kg/m2 and fasting blood glucose <5.5 mmol/L. Subjects taking
medications or dietary supplements were excluded. The study was
conducted at the University of Sydney and was approved by the
Human Research Ethics Committee of the University of Sydney.
Informed written consent was obtained from all subjects before the
start of the study.
The study was an incomplete block design, with the three inulin
controls (containing 5 g Orafti® inulin, sourced from Beneo, a low
viscosity ﬁbre) consumed at the beginning, middle and end of the
study, and 2.5 g, 5 g and 7.5 g of PGX® ﬁbre consumed in random
order. All subjects fasted for 10–12 h overnight, then came to the
test room on the samemorning, but at different times between 6.30
and 8.30 a.m. and were randomly allocated to one of the test con-
ditions. On arrival, subjects entered the test roomwhere they were
asked to sign the consent form. Subjects answered the question
“what time was your last meal?” on the satiety questionnaire. All
subjects participated in six 2-h test sessions, separated by a two-
or three-day wash-out period, thus up to two tests per week.
Subjects were assigned a three digit number and randomised
to one of the test conditions. Condition 1 was: inulin control on
test day 1; 2.5 g PGX® on test day 2; inulin control on test day 3;
7.5 g PGX® on test 4; inulin control on test day 5; and 5 g PGX® on
test day 6. Condition 2 was: 5 g PGX® on the ﬁrst test day; inulin
control on test day 2; 2.5 g PGX® on test day 3; inulin control on
test day 4; 7.5 g PGX® on test day 5; and inulin control on test day
6. Condition 3 was: inulin control on test day 1; 7.5 g PGX® on test
day 2; inulin control on test day 3; 5 g PGX® on test day 4; inulin
control on test day 5; and 2.5 g PGX® on test day 6. The PGX® for
the additional conditions was randomised according to the block
design. The inulin control and PGX® granules were consumed as
part of a standardmeal (which included Tip Topwhite bread, George
Weston Foods, Sydney, NSW, Australia), which contained 50 g of
available carbohydrate (deﬁned as total carbohydrate minus dietary
ﬁbre). The inulin control and PGX® granules were dissolved in
2 × 250ml glasses of water and consumed with the standard meal.
Suﬃcient water was used to hydrate the product before consump-
tion and eliminate the effects of its hydrophobic nature post con-
sumption. The subjects consumed the test meal within 12 min (2
glasses of water containing PGX® within the ﬁrst 5 min and bread
within 12min) and completed a 150mm visual analogue scale (VAS)
before the start of eating (time 0). After this, subjects remained in
the testing room for 120min to rate their appetite and provide ﬁnger
prick blood samples at 15, 30, 45, 60, 90 and 120min after the start
of eating.
Palatability (liking)
Palatability was determined using a Likert scale to access “liking”.
The question “How much did you like this food?” was rated on a
150 mm Likert scale, marked with 7 descriptors that ranged from
“dislike very much” to “like very much”, where “dislike very
much” = −3, “dislike moderately” = −2, “dislike slightly” = −1, “neither
like nor dislike” = 0, “like slightly” = 1, “likemoderately” = 2, and “like
very much” = 3.
Dietary acceptance was assessed using the question, “How dif-
ﬁcult was the food to eat?”, which was rated on a 100mm VAS, an-
chored at both ends with 2 descriptors, “not diﬃcult at all” which = 0
and “extremely diﬃcult” which = 10.
Satiety measurement
The question “How hungry do you feel now?” was determined
on a 150mm VAS, where the scale was anchored at equally spaced
intervals with words to describe the feeling of hunger from
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“extremely hungry” to “extremely full”, as previously described by
Holt, Brand-Miller, Petocz, and Farmakalidis (1995). The VAS was
an unmarked 150 mm horizontal line and subjects placed a verti-
cal line along the ﬁrst 75mm of the VAS to correspond with hunger
or along the second 75 mm to correspond with fullness (Fig. 1).
The score on the VAS was measured for each subject from the
centre point, so a maximum of 75 mm equated to “extremely full”
and negative 75mm to “extremely hungry”. The University of Sydney
converts VAS results to a satiety score of 1 to 3 for satiety, where a
score of slightly full is 25 mm on the VAS and is assigned a score
of 1, 50 mm a score of 2 and 75 mm a score of 3. The results from
each subject’s VAS were entered into Microsoft Excel. The incre-
mental area under the curve (iAUC) was calculated for each subject
(n = 10) using the trapezoidal method. The VAS at time 0 (fasting
result) was subtracted from the subject’s fullness rating at each time
measured (15–120min), and the baselinewas adjusted to 0. The iAUC
was determined to show change in satiety from the baseline, so the
fasting satiety level at the baseline was subtracted from subse-
quent values.
Plasma glucose measurement
The subjects fasted overnight for at least 10 h and arrived at the
metabolic kitchen in the morning. Each subject was weighed, and
two fasting blood samples were collected by ﬁnger-prick. The subject
consumed the test meal within 12 min, and further blood samples
were obtained at 15, 30, 45, 60, 90 and 120 min after the start of
eating. Whole blood samples (0.7 mL) were collected from the ﬁn-
gertip into heparin-coated, micro-centrifuge tubes prior to con-
sumption of the test meal (time 0) and at 15, 30, 45, 60, 90 and 120
minutes after eating commenced. Each blood sample was centri-
fuged for 45 s at 12 500× g. The plasma glucose concentration was
analysed in duplicate using a glucose hexokinase enzymatic assay
on an automatic spectrophotometric analyser (Roche Diagnostic
Systems, Sydney, NSW, Australia).
Statistical analysis
The incremental area under the curve (iAUC) of test meals
with PGX® at different dose levels from baseline to time 120 min
was used as an outcome variable. The multilevel mixed-effects
linear regression was used to assess the difference in iAUC between
the control and the different doses (2.5 g, 5.0 g, 7.5 g). Amixedmodel
was used to address the intraclass correlation, as each subject
was tested 6 times. The test groups variable was entered into
the model as a ﬁxed effect, and the subjects’ ID was entered as the
random effect, according to the structure of the panel data. The
standard error was further adjusted using the vce (robust) option
in the Stata program accounting for intragroup correlation. A
regression model was used to determine the association between
plasma glucose, PGX® dose and fullness. All analyses were
performed using Stata statistical software (SE 12.1, StataCorp, College
Station, TX, USA).
Results
Palatability
The subject’s rating of “Howmuch did you like this food?” (n = 10
and each subject conducted the test 3 times) resulted in a “neither
like nor dislike/like slightly” rating, with a mean of 0.1 ± 1.0 and a
median of 0. There was no signiﬁcance difference in the rating for
all test products, when consumed with the standard meal. Sub-
jects found the test meal not diﬃcult to eat, with a mean rating of
3 ± 2.0.
Fullness rating
Fullness (iAUC) (calculated bymm timesminutes and rating times
minutes) and VAS fullness (rating) increased for all test products
compared to the control (Table 1 and Fig. 2).
PGX® exhibited a signiﬁcant impact on short-term satiety asmea-
sured by iAUC for fullness over time. The iAUC results show the
control (0g PGX®) iAUC was signiﬁcantly different from 2.5 g PGX®
(P = 0.025) and 7.5 g PGX® (P = 0.001). The 2.5 g and 5 g iAUC were
signiﬁcantly different (P = 0.0009 and 0.0361, respectively) from 7.5 g.
There was no signiﬁcant difference between iAUC fullness for the
three controls, with iAUC values of 2214, 2256 and 2442mm × min
or 88.6, 90.2, 97.7 rating × min (P = 0.105 and P = 0.587).
The PGX® doses of 2.5 and 7.5 g, mixed with water at the start
of breakfast, increased satiety (iAUC of 140.0 and 157.7, P = 0.025 and
0.001, respectively) compared with the control. The PGX® dose of
5 g mixed with water at the start of breakfast increased satiety to
the 60 min time point compared with the control. The lack of dose
linearity may be due to within subject variability when rating full-
ness, past the 60 min time point. All subjects (n = 10) ranked PGX®
at 7.5 g as providing greater VAS fullness than the control at 15, 30,
45, 60 and 90 min. All subjects ranked inulin control as providing
the least VAS fullness for 15, 30, 45 and 60 min.
“How hungry or full do you feel right now?”   
extremely hungry slightly no       slightly     full     extremely
hungry hungry      particular full full
feeling
Fig. 1. Visual Analogue Scale (VAS).
Table 1
Fullness (iAUC) for VAS in mm and as a rating (1 to 3).
Test food Area under the curve
(iAUC) mean fullness and
SD (mm.min)
Area under the curve
(iAUC) mean fullness and
SD (rating.min)
7.5 g 3942c ± 2250 157.7f ± 90
5 g 2937a ± 1750 117.5d ± 70
2.5 g 3501b ± 2070 140.0e ± 83
0 g 2304a ± 2200* 92.2d ± 88*
Mean values in same column followed by a different letter are signiﬁcantly differ-
ent (P < 0.05).
* Average of 3 control samples.
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Relationship with postprandial glycaemia
The same subjects used for the satiety study also had blood
samples obtained by ﬁnger-prick measured for plasma glucose
(mmol/L). Incremental AUC plasma glucose (mmol/L.min)was 151 ± 5
after the consumption of the inulin control, 113 ± 9 after 2.5 g PGX®,
88 ± 9 after 5 g PGX® and 76 ± 9 after 7.5 g PGX®, showing a nega-
tive relationship with fullness iAUC; i.e. as fullness iAUC
(0–60min) increased, plasma glucose iAUC decreased. Both plasma
glucose and PGX® dose was associated with fullness (P = 0.01).
The highest dose of PGX® reduced the plasma glucose iAUC by
50% from 151 ± 5 to 76 ± 9 mM/120min (P < 0.005) (previously re-
ported by Brand-Miller et al., 2010). The overall trend for reduc-
tion in plasma glucose with increasing dose of PGX® was signiﬁcant,
P < 0.001. There was no missing data as all subjects completed the
study.
Discussion
Signiﬁcantly greater fullness (VAS) was found from the test meals
which included PGX®, comparedwith the controlmealwithout PGX®.
Several factors may have contributed to the higher ratings of full-
ness, including the viscosity of the PGX® ﬁbre, themixing of the PGX®
ﬁbre with water prior to consumption, as well as the amount or ﬁbre
dose.
Drewnowski (1998) and Ellis, Apling, Leeds, and Bolster (1981)
reported the importance of acceptability and palatability in satiety
studies. Satiety studies are complex, especially in the study of mixed
meals (Hlebowicz, 2009). Mixed meals may be more likeable, but
the macronutrients, as well as the physiological properties and the
digestibility of the different ﬁbre types and other components of the
meal, must be considered. PGX®, plus white bread was palatable,
and enabled the understanding of the role of the PGX® in an un-
complicated environment.
Our study found the control (5 g inulin) had a much lower effect
on satiety compared to PGX®, but as inulin was part of the control
meal with bread, it cannot be concluded that it provides any satiety
effect above that of the bread. The inulin dose used as the control
in the present study also had no apparent effect on lowering GI in
the parallel study (Brand-Miller et al., 2010, 2012). Karalus et al.
(2012) also reported that all the ﬁbre in their study (10 g each of
oligofructose, inulin, soluble corn ﬁbre or resistant wheat starch),
when incorporated into a chocolate crisp product, produced greater
gastrointestinal symptoms, but did not alter short-term satiety,
hunger or food intake compared with the control.
The negative relationship between fullness and plasma glucose
found in this research is supported in research by Keogh,
Atkinson, Eisenhauer, Inamdar, and Brand-Miller (2011) who also
found a negative relationship between iAUC plasma glucose (mmol/
L.min) and feelings of fullness in a study comparing high dietary
ﬁbre Burgen bread and lupin bread to white bread.
There appears to be a need for suﬃcient water for dietary ﬁbre
to be effective in providing a satiety effect. Guérin-Deremaux et al.
(2011) found ﬁbre in orange juice had an effect on satiety and Calame,
Thomassen, Hull, Viebke, and Siemensma (2011) found gum Arabic
dissolved in water enhanced satiety. In contrast, products contain-
ing ﬁbre, that were consumed dry, even if consumed alongsidewater,
have not supported the case for adding ﬁbre to dry foods. Wanders
et al. (2013) found biscuits with added alginate ﬁbre reduced ad
libitum intake, but those with guar ﬁbre did not. Neither the bis-
cuits with alginate ﬁbre nor guar ﬁbre affected satiation (Wanders
et al., 2013). Mattes (2007) found guar and alginate ﬁbre combina-
tions in a solid food matrix did not affect appetite or acute food
intake.
Conclusion
When included as part of a breakfast meal, PGX® resulted in in-
creased fullness iAUC and provided an improved satiety effect com-
pared with breakfast without PGX®. The ﬁndings provide further
evidence that satiety and postprandial glycaemia response are con-
nected, and it appears that both may be dictated by viscosity and
the effect of blood glucose. Plasma glucose and PGX® dose was as-
sociated with fullness. A viscous product that forms a gel post con-
sumption to provide a physical feeling of fullness, requires suﬃcient
water to gel, slows gastric emptying, slows the release of glucose
into the blood and contributes to the satiety effect would be a pow-
erful satiety agent. PGX® forms gel and has a very strong effect on
satiety, especially at the 7.5 g dose, and delays the postprandial gly-
caemia response, but further research is needed to determine if these
beneﬁts are to be maintained long term.
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